Frontline Combination of Hyper-CVAD with Ponatinib for Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia-6-Year Follow-up Results

被引：1

作者：

Nasnas, Patrice ^{[1
]}

Jabbour, Elias ^{[1
]}

Short, Nicholas ^{[1
]}

Sasaki, Koji ^{[1
]}

Ravandi, Farhad ^{[1
]}

Jain, Nitin ^{[2
]}

Daver, Naval ^{[1
]}

Pemmaraju, Naveen ^{[1
]}

Yilmaz, Musa ^{[2
]}

Kadia, Tapan M. ^{[2
]}

Garris, Rebecca ^{[1
]}

Garcia-Manero, Guillermo ^{[1
]}

DiNardo, Courtney D. ^{[1
]}

Konopleva, Marina ^{[3
]}

Wierda, William G. ^{[4
]}

Kwari, Monica ^{[1
]}

Loiselle, Christopher ^{[1
]}

Milton, Anna ^{[1
]}

Rivera, Juan ^{[1
]}

Banks, Glenda ^{[1
]}

Kantarjian, Hagop ^{[5
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

[2] MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA

[3] MD Anderson Canc Ctr, Houston, TX USA

[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[5] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Div Canc Med, Houston, TX 77030 USA

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-167761

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3250 / 3252

页数：3

共 50 条

[31] Combination therapy with low doses of ponatinib and steroids in elderly and frail patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
Takafumi Tsushima
Nobue Sato
Yong-Mei Guo
Satoshi Uchiyama
Hirotaka Nakamura
Akihito Nagata
Chi Song-Gi
Nobuhiko Yamauchi
Yosuke Minami
Junichiro Yuda
Annals of Hematology, 2022, 101 : 1603 - 1605
[32] Combination therapy with low doses of ponatinib and steroids in elderly and frail patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
Tsushima, Takafumi
Sato, Nobue
Guo, Yong-Mei
Uchiyama, Satoshi
Nakamura, Hirotaka
Nagata, Akihito
Song-Gi, Chi
Yamauchi, Nobuhiko
Minami, Yosuke
Yuda, Junichiro
ANNALS OF HEMATOLOGY, 2022, 101 (07) : 1603 - 1605
[33] Phase II Study Of Combination Of Hyper-CVAD With Ponatinib In Front Line Therapy Of Patients (pts) With Philadelphia Chromosome (Ph) Positive Acute L phoblastic Leukemia (ALL)
Jabbour, Elias
Kantarjian, Hagop
Thomas, Deborah A.
Ravandi, Farhad
Cortes, Jorge E.
Faderl, Stefan H.
Pemmaraju, Naveen
Kadia, Tapan M.
Garris, Rebecca
Hillary, Prescott
Garcia-Manero, Guillermo
Borthakur, Gautam
Wierda, William G.
O'Brien, Susan
BLOOD, 2013, 122 (21)
[34] Clinical experience with frontline Hyper-CVAD-based regimens, including Hyper-CVAD plus ponatinib, in patients with acute lymphoblastic leukemia treated at a comprehensive cancer center
Othman, Tamer
Moskoff, Benjamin N.
Ho, Gwendolyn
Tenold, Matthew E.
Azenkot, Tali
Krackeler, Margaret L.
Fisch, Samantha C.
Potter, Laura A.
Kaesberg, Paul R.
Welborn, Jeanna L.
Wun, Ted
Esteghamat, Naseem S.
Hoeg, Rasmus T.
Rosenberg, Aaron S.
Abedi, Mehrdad
Tuscano, Joseph M.
Jonas, Brian A.
LEUKEMIA RESEARCH, 2022, 119
[35] Combination of ponatinib and blinatumomab in Philadelphia chromosome-positive acute lymphoblastic leukemia: Early results from a phase II study.
Short, Nicholas James
Kantarjian, Hagop M.
Konopleva, Marina
Jain, Nitin
Huang, Xuelin
Ravandi, Farhad
Wierda, William G.
Borthakur, Gautam
Sasaki, Koji
Issa, Ghayas C.
Alvarado, Yesid
Pemmaraju, Naveen
Garcia-Manero, Guillermo
Thankachan, Jennifer
Garris, Rebecca
Jabbour, Elias
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[36] Phase II study of ponatinib and blinatumomab in Philadelphia chromosome-positive acute lymphoblastic leukemia
Sasaki, Koji
Kantarjian, Hagop
Konopleva, Marina
Jain, Nitin
Huang Xuelin
Ravandi, Farhad
Wierda, William
Borthakur, Gautam
Short, Nicholas
Issa, Ghayas
Alvarado, Yesid
Pemmaraju, Naveen
Garcia-Manero, Guillermo
Thankachan, Jennifer
Garris, Rebecca
Jabbour, Elias
ANNALS OF ONCOLOGY, 2022, 33 : S466 - S466
[37] Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
Daver, Naval
Thomas, Deborah
Ravandi, Farhad
Cortes, Jorge
Garris, Rebecca
Jabbour, Elias
Garcia-Manero, Guillermo
Borthakur, Gautam
Kadia, Tapan
Rytting, Michael
Konopleva, Marina
Kantarjian, Hagop
O'Brien, Susan
HAEMATOLOGICA, 2015, 100 (05) : 653 - 661
[38] Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy
Short, Nicholas J.
Jabbour, Elias
Nasr, Lewis F.
Jain, Nitin
Haddad, Fadi G.
Issa, Ghayas C.
Sasaki, Koji
Senapati, Jayastu
Kebriaei, Partow
Garris, Rebecca
Konopleva, Marina
Ravandi, Farhad
Kantarjian, Hagop
AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (07) : 1423 - 1426
[39] Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia
Lim, Sung-Nam
Joo, Young-Don
Lee, Kyoo-Hyung
Kim, Dae-Young
Lee, Je-Hwan
Lee, Jung-Hee
Chi, Hyun-Sook
Yun, Sung-Cheol
Lee, Won Sik
Lee, Sang Min
Park, Seonyang
Kim, Inho
Sohn, Sang Kyun
Moon, Joon Ho
Ryoo, Hun-Mo
Bae, Sung Hwa
Hyun, Myung Soo
Kim, Min Kyoung
Kim, Hyeoung Joon
Yang, Deok-Hwan
Eom, Hyeon-Seok
Lee, Gyeong-Won
Jung, Chul Won
Won, Jong-Ho
Kim, Hawk
Lee, Jae-Hoon
Shin, Ho-Jin
Jang, Dae-Young
AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (11) : 1013 - 1020
[40] Long-term follow-up after frontline therapy with the Hyper-CVAD and imatinib mesylate regimen in adults with Philadelphia (Ph) positive acute lymphocytic leukemia (ALL)
Thomas, Deborah A.
Kantarjian, Hagop M.
Ravandi, Farhad
Faderl, Stefan
Garcia-Manero, Guillermo
Wierda, William
Ferrajoli, Alessandra
Vertovsek, Srdan
Jones, Dan
Letvak, Laurie
Champlin, Richard
Cortes, Jorge
O'Brien, Susan
BLOOD, 2007, 110 (11) : 10A - 11A

← 1 2 3 4 5 →